G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2004
11/18/2004	WO2004099784A2 Method for determining a tissue degradation process by detection of fibromodulin neoepitopes
11/18/2004	WO2004099783A2 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor ltb4 (ltb4)
11/18/2004	WO2004099782A2 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor gpr39 (gpr39)
11/18/2004	WO2004099781A2 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor rdc1 (rdc1)
11/18/2004	WO2004099780A1 Immunoassays for the detection of urokinase receptor forms
11/18/2004	WO2004099779A1 Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 3 (tmprss3)
11/18/2004	WO2004099778A1 Sensor system for saccharides
11/18/2004	WO2004099777A2 Multicoated or multilayer entrapment matrix for protein biosensor
11/18/2004	WO2004099776A1 Biochip support comprising thin layers of sol-gel material and production method thereof
11/18/2004	WO2004099775A1 Means for detecting protein conformation and applications thereof
11/18/2004	WO2004099774A2 Processes for the identification of medical targets by screening an active agent for binding interactions
11/18/2004	WO2004099773A1 Automated in vitro cellular imaging assays for micronuclei and other target objects
11/18/2004	WO2004099772A2 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor agtr1a (agtr1a)
11/18/2004	WO2004099771A1 A new specific epitope based immunological diagnosis of tuberculosis
11/18/2004	WO2004099770A1 Method for identifying modulators of clk-1 and ubif activity
11/18/2004	WO2004099769A1 Device and method for measuring metal inclusions
11/18/2004	WO2004099768A1 Method for detecting development of a physiological disorder in a subject
11/18/2004	WO2004099767A2 Biomolecular switching device using a holliday junction dna
11/18/2004	WO2004099763A1 Automated characterization and classification of microoganisms
11/18/2004	WO2004099566A1 A method and apparatus for an advanced optical analyzer
11/18/2004	WO2004099564A2 A method and apparatus for a downhole micro-sampler
11/18/2004	WO2004099525A2 Reaction module for biological analysis
11/18/2004	WO2004099444A2 Diagnostic methods
11/18/2004	WO2004099438A1 One step oligochromatographic device and method of use
11/18/2004	WO2004099437A1 Fluorescent methods for the high-throughput quantification of tartrate-resistant acid phosphatase (trap)
11/18/2004	WO2004099432A2 Identification of biomarkers for detecting pancreatic cancer
11/18/2004	WO2004099430A2 Substrate in the form of a ligate carrier
11/18/2004	WO2004099424A2 Enrichment of enzymatic cleavage products
11/18/2004	WO2004099421A1 Multiple gene transcription activity determining sysyem
11/18/2004	WO2004099407A1 Method of testing sensitivity to anticancer drug
11/18/2004	WO2004099404A2 Bioinformatic method for predicting functional equivalence between biological sequences
11/18/2004	WO2004099395A2 A method for the generation of neural progenitor cells
11/18/2004	WO2004099393A1 Method for storing tumor cells
11/18/2004	WO2004099384A2 Solid phase cell lysis and capture platform
11/18/2004	WO2004099383A2 Chromatographic assay system
11/18/2004	WO2004099379A2 Use of jag2 expression in diagnosis of plasma cell disorders
11/18/2004	WO2004099376A2 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity
11/18/2004	WO2004099368A2 Methods for detecting intracellular defensins in various leukocyte subpopulations
11/18/2004	WO2004099307A2 Nanocylinder-modified surfaces
11/18/2004	WO2004099219A2 Silanyl n-alkanal compounds, method for production and use thereof
11/18/2004	WO2004099106A2 Facilitated forward chemical genetics using tagged triazine library
11/18/2004	WO2004098764A2 Multi-well plate providing a high-density storage and assay platform
11/18/2004	WO2004098741A2 Apparatus and method for detecting live cells with an integrated filter and growth detection device
11/18/2004	WO2004098647A2 Claudins’ underexpression as markers of tumor metastasis
11/18/2004	WO2004098639A1 METHOD OF CONTROLLING TGFβ-ORIGIN APOPTOSIS
11/18/2004	WO2004098634A2 Protein arginine n-methyltransferase 2 (prmt-2)
11/18/2004	WO2004098628A2 Synthetic peptide analogs of arg-pro-pro-gly-phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
11/18/2004	WO2004098521A2 Treatment and diagnostics of cancer
11/18/2004	WO2004098497A2 Cd4+ human papillomavirus (hpv) epitopes
11/18/2004	WO2004098487A2 Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 5 (tmprss5)
11/18/2004	WO2004098391A2 Methods for detecting parvovirous infections
11/18/2004	WO2004098384A2 Parallel analysis of molecular interactions
11/18/2004	WO2004098377A2 Methods and compositions for diagnosis and therapy of parkin-associated disorders
11/18/2004	WO2004090537A3 Methods to individualize combination therapy
11/18/2004	WO2004087281A9 Implementation of microfluidic components, including molecular fractionation devices, in a microfluidic system
11/18/2004	WO2004086026A3 Method for testing prestressed concrete pipes
11/18/2004	WO2004083853A3 Test system for the discovery of substances for the promotion of neuraxonal growth
11/18/2004	WO2004082573A3 Diagnostics and therapeutics for diseases associated with dopamine receptor d4 (drd4)
11/18/2004	WO2004080288A3 Post-translational modifications of proteins as regulatory switches
11/18/2004	WO2004078934A8 Targeting site-2 protease (s2p) for the treatment of pancreatic cancer
11/18/2004	WO2004078778A3 PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (cMet) AND USES THEREOF
11/18/2004	WO2004075865A3 Selective modulation of tlr-mediated biological activity
11/18/2004	WO2004074841A3 Kor3l-like-proteins and methods of modulating kor3l-mediated activity
11/18/2004	WO2004074246A3 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
11/18/2004	WO2004070062A3 Compositions and methods for diagnosing and treating cancers
11/18/2004	WO2004069193A9 Methods and compositions for inhibiting cholesterol uptake
11/18/2004	WO2004066361A3 Monodisperse core/shell and other complex structured nanocrystals and methods of preparing the same
11/18/2004	WO2004065616A3 Use of three-dimensional microfabricated tissue engineered systems for pharmacologic applications
11/18/2004	WO2004062686A3 Therapeutic use of modulators of notch
11/18/2004	WO2004054603A3 Use of beta-defensins for treating hiv infections
11/18/2004	WO2004051565A3 Optical tomography of small objects using parallel ray illumination and post-specimen optical magnification
11/18/2004	WO2004048591A3 Methods for cohort selection and longevity studies
11/18/2004	WO2004047128A3 Rare earth metal sensor
11/18/2004	WO2004046337A3 Multilayered microcultures
11/18/2004	WO2004042364B1 Assay device, system and method
11/18/2004	WO2004038406A3 Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 42 (gpr42)
11/18/2004	WO2004036181A3 Method of treating neurological diseases and disorders
11/18/2004	WO2004029602A3 Phased micro analyser
11/18/2004	WO2004016586A3 Compositions and methods related to flavivirus envelope protein domain iii antigens
11/18/2004	WO2004011902A3 Improved systems and methods for analysis of protein post-translational modification
11/18/2004	WO2003102156A3 Heterologous stimulus-gated ion channels and methods of using same
11/18/2004	WO2003100002A3 Predicting the significance of single nucleotide polymorphisms (snps) using ensemble-based structural energetics
11/18/2004	WO2003095624A3 Liver inflammation predictive genes
11/18/2004	WO2003089665A8 Methods for measuring protein kinase and phosphatase activity
11/18/2004	WO2003085179A8 Spinning preparation machine with microwave sensors
11/18/2004	WO2003080805A3 Kinases and phosphatases
11/18/2004	WO2003055982A3 Compositions and methods relating to endometrial specific genes and proteins
11/18/2004	WO2003046205A3 Methods for identifying modulators of apoptosis
11/18/2004	WO2002090499A3 ss-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
11/18/2004	US20040231013 Transgenic mouse expressing fluorescent protein for use of whole body imaging in comparative disease diagnosis and prognosis; colorimetric analysis
11/18/2004	US20040231010 Lysozyme transgenic ungulates
11/18/2004	US20040231009 Using variation in sensory organ developmental genes to diagnose and treat nervous system disorders; tissue engineering and gene therapy
11/18/2004	US20040231008 Using transgenic worms comprising vector coding neuronal membrane protein as diagnostic indicator of neurosensory agonist; chemotaxis
11/18/2004	US20040231005 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases
11/18/2004	US20040230443 System and method of creating, aggregating, and transferring environmental emisssion reductions
11/18/2004	US20040230352 Record and playback system for aircraft
11/18/2004	US20040230152 Extra-corporeal Blood Processing Method and Apparatus Based on Donor Characteristics
11/18/2004	US20040230064 Novel labeled resiniferatoxin derivatives
11/18/2004	US20040230043 Novel neurotrophic factors
11/18/2004	US20040230037 Chemokine receptor materials and methods

1 ... 2230 2231 2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 2242 2243 2244 2245 2246 2247 2248 2249 2250 ... 3937